Akari Therapeutics
BioTech/Drugs - New York, NY, US
Akari Therapeutics Employees
Akari Therapeutics Senior Management
Akari Therapeutics Details
Akari is a biopharmaceutical company focused on developing inhibitors of acute and chronic inflammation, specifically for the treatment of rare and orphan diseases, in particular those where the complement (C5) or leukotriene (LTB4) systems, or both complement and leukotrienes together, play a primary role in disease progression. Akari's lead drug candidate, nomacopan (formerly known as Coversin), is a C5 complement inhibitor that also independently and specifically inhibits leukotriene B4 (LTB4) activity.
Website:
akaritx.com
Employees:
20 - 49
HQ:
929-274-7510
Location:
New York, NY, US
Revenue:
2.5 - 5 Million
Akari Therapeutics Technologies
Email Providers
Outlook
CMS
WordPress.org
Hosting
GoDaddy Hosting
Search Marketing
Adobe Marketing Cloud
Online Video Platforms
YouTube